AB-452

N/A

Report date: 2025/04/14 15:43:00
NME

Base Information

Drug NameAB-452
Drug Alias NameAB-452
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTerminal nucleotidyltransferase 4A inhibitorsTerminal nucleotidyltransferase 4B inhibitors
TargetsTerminal nucleotidyltransferase 4ATerminal nucleotidyltransferase 4B
Therapy Area/IndicationsHepatitis B, ChronicHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySingaporeRomaniaNew Zealand +[6] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBaruch S. Blumberg InstituteAlumni Association Of Drexel University College Of Medicine
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBaruch S. Blumberg InstituteAlumni Association Of Drexel University College Of MedicineArbutus Biopharma Corp
Active IndicationsN/A
Inactive IndicationsHepatitis B, ChronicHepatitis B

Other Information

ATC CodeN/A
Related LinksN/A